Literature DB >> 12903020

Spinal cord and peripheral nerve injury: current management and investigations.

William H St Clair1, Susanne M Arnold, Andrew E Sloan, William F Regine.   

Abstract

Treatment of patients having malignancy near or within the spinal cord can be more challenging or limited than in patients with brain tumors. This is largely because of the near total lack of noneloquent neural tissue associated with the spinal cord and/or intimately associated peripheral nerves. The adverse effects of surgery, radiation therapy, and chemotherapy or multimodality therapy can be acute or chronic, insidious, and often permanent in nature. Because cancer therapies (particularly combination therapies) have become more effective with regard to tumor control, the potential impact of each modality on spine and peripheral nerve injury has become even more significant. Similarly, with increasing survival, the likelihood of observing long-term injury is likely to increase. Thus, the expression of acute and long-term spine and peripheral nerve injury is becoming a more important factor in the management of patients with spine malignancies. This review presents current management and investigations associated with these modality-related injuries.

Entities:  

Mesh:

Year:  2003        PMID: 12903020     DOI: 10.1016/s1053-4296(03)00025-0

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  6 in total

1.  Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms.

Authors:  Daniel Pak; Karen Vineberg; Felix Feng; Randall K Ten Haken; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-26       Impact factor: 7.038

2.  The Feasibility of Spinal Stereotactic Radiosurgery for Spinal Metastasis with Epidural Cord Compression.

Authors:  Yi-Jun Kim; Jin Ho Kim; Kyubo Kim; Hak Jae Kim; Eui Kyu Chie; Kyung Hwan Shin; Hong-Gyun Wu; Il Han Kim
Journal:  Cancer Res Treat       Date:  2019-01-29       Impact factor: 4.679

3.  Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphoma.

Authors:  Bassem Youssef; JoAnn Shank; Jay P Reddy; Chelsea C Pinnix; George Farha; Mani Akhtari; Pamela K Allen; Michelle A Fanale; John A Garcia; Patricia H Horace; Sarah Milgrom; Grace Li Smith; Yago Nieto; Isadora Arzu; He Wang; Nathan Fowler; Maria Alma Rodriguez; Bouthaina Dabaja
Journal:  Radiat Oncol       Date:  2015-09-25       Impact factor: 3.481

4.  Lhermitte's Sign following VMAT-Based Head and Neck Radiation-Insights into Mechanism.

Authors:  Huaising C Ko; Allison R Powers; Ren-dih Sheu; Sarah L Kerns; Barry S Rosenstein; Stephen C Krieger; Waleed F Mourad; Kenneth S Hu; Vishal Gupta; Richard L Bakst
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

5.  Identifying risk factors for L'Hermitte's sign after IMRT for head and neck cancer.

Authors:  Hannah M Laidley; David J Noble; Gill C Barnett; Julia R Forman; Amy M Bates; Richard J Benson; Sarah J Jefferies; Rajesh Jena; Neil G Burnet
Journal:  Radiat Oncol       Date:  2018-05-04       Impact factor: 3.481

6.  Comparison of pre-implant treatment planning and post-implant dosimetry in I-125 spinal metastases brachytherapy.

Authors:  Guohua Chen; Mingyong Han
Journal:  Oncol Lett       Date:  2019-11-18       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.